CSIMarket
 
Verve Therapeutics Inc   (NASDAQ: VERV)
 

Verve Therapeutics Inc's Suppliers Performance

VERV's Supply Chain




 
VERV Costs vs Sales of Suppliers Growth

More on VERV Suppliers






Verve Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party contract manufacturing organizations (CMOs) to supply critical starting materials such as gRNA and mRNA, support IND-enabling studies, clinical trials, and future commercial activities. They intend to expand their CMO network as manufacturing scales. Multiple sources are available for all materials required for their product candidates, and multiple CMOs can assemble program components. The company is investing in RNA production, lipid nanoparticle (LNP) formulation, and analytical method development, including bioactivity and potency assays. Manufacturing is conducted in compliance with current Good Manufacturing Practices (cGMP) and other regulations, with CMOs required to adhere to these standards and undergo regular monitoring and audits. The company employs personnel with technical, manufacturing, analytical, and quality expertise to oversee contracted manufacturing and testing activities.

Verve Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party contract manufacturing organizations (CMOs) to supply critical starting materials such as gRNA and mRNA, support IND-enabling studies, clinical trials, and future commercial activities. They intend to expand their CMO network as manufacturing scales. Multiple sources are available for all materials required for their product candidates, and multiple CMOs can assemble program components. The company is investing in RNA production, lipid nanoparticle (LNP) formulation, and analytical method development, including bioactivity and potency assays. Manufacturing is conducted in compliance with current Good Manufacturing Practices (cGMP) and other regulations, with CMOs required to adhere to these standards and undergo regular monitoring and audits. The company employs personnel with technical, manufacturing, analytical, and quality expertise to oversee contracted manufacturing and testing activities.







VERV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Verve Therapeutics Inc 988.30 59.61 -181.01 21
SUBTOTAL 0.00 0.00 0.00 -


Sources: Verve Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Verve Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.